At least they advised in the presentation what the phase 2 will look like and the fact they will be start enrolling for phase two while running the natural history study concurrently.
Alterity will take “data cuts” from the study to optimize the endpoints while enrollment is started ( enrollment expected to start h2 2021).
Ann: Alterity participates in JP Morgan healthcare conference, page-6
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $13.30K | 2.494M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 42 | 38650496 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 14296830 | 20 |
View Market Depth
| Last trade - 16.10pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 9.09 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 4509722 | ||
| Last updated 13.41pm 27/05/2024 ? | |||||
| ATH (ASX) Chart |